MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 49 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $957,922 | +47988.5% | 309,007 | -55.8% | 0.05% | -44.6% |
| Q2 2023 | $1,992 | -27.7% | 698,861 | 0.0% | 0.09% | -31.9% |
| Q1 2023 | $2,754 | -99.9% | 698,861 | 0.0% | 0.14% | -7.5% |
| Q4 2022 | $2,767,490 | -56.9% | 698,861 | 0.0% | 0.15% | -59.6% |
| Q3 2022 | $6,423,000 | -53.4% | 698,861 | -68.8% | 0.36% | -58.6% |
| Q2 2022 | $13,769,000 | -4.2% | 2,238,861 | 0.0% | 0.87% | +18.0% |
| Q1 2022 | $14,373,000 | -2.0% | 2,238,861 | 0.0% | 0.74% | +29.6% |
| Q4 2021 | $14,665,000 | -0.1% | 2,238,861 | -13.0% | 0.57% | +11.1% |
| Q3 2021 | $14,687,000 | +3.8% | 2,572,194 | 0.0% | 0.51% | +2.8% |
| Q2 2021 | $14,147,000 | -5.0% | 2,572,194 | 0.0% | 0.50% | -1.2% |
| Q1 2021 | $14,893,000 | -10.3% | 2,572,194 | +3.8% | 0.50% | -5.4% |
| Q4 2020 | $16,597,000 | +27.6% | 2,477,194 | +39.4% | 0.53% | +18.7% |
| Q3 2020 | $13,009,000 | +212.3% | 1,777,194 | +61.2% | 0.45% | +145.9% |
| Q2 2020 | $4,166,000 | +105.4% | 1,102,194 | 0.0% | 0.18% | +32.6% |
| Q1 2020 | $2,028,000 | -88.5% | 1,102,194 | 0.0% | 0.14% | -86.2% |
| Q4 2019 | $17,646,000 | -14.2% | 1,102,194 | 0.0% | 1.00% | -33.0% |
| Q3 2019 | $20,556,000 | -31.3% | 1,102,194 | 0.0% | 1.49% | -42.1% |
| Q2 2019 | $29,925,000 | – | 1,102,194 | – | 2.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,425,737 | $22,293,000 | 3.44% |
| Lion Point Capital, LP | 1,557,233 | $11,186,000 | 2.46% |
| ACUTA CAPITAL PARTNERS, LLC | 597,026 | $5,487,000 | 2.36% |
| Ikarian Capital, LLC | 855,616 | $7,863,000 | 1.57% |
| GREAT POINT PARTNERS LLC | 674,656 | $6,200,000 | 1.49% |
| Bleichroeder LP | 512,500 | $4,710,000 | 0.98% |
| RTW INVESTMENTS, LP | 4,315,102 | $39,656,000 | 0.91% |
| Novo Holdings A/S | 2,000,000 | $18,380,000 | 0.88% |
| Paradigm Biocapital Advisors LP | 634,211 | $5,828,000 | 0.78% |
| Ikarian Capital, LLC | 338,000 | $3,107,000 | 0.62% |